Purchase Order 36C26024P0864
Award Date
8/1/24
Potential Completion Date
7/31/29
Potential Value
$247K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Fulgent Genetics, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portland, OR 97239, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,489,759.80 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The contract is for germline genetic testing services to support the VA's National Oncology Program. It is an indefinite delivery, indefinite quantity (IDIQ) contract with a one-year base period and two one-year options. The contract provides national access to genetic testing...
This is a federal contract award from the Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The $2,300,000 firm fixed-price delivery order is for germline pharmacogenomic molecular testing services, with a period of performance through September 30, 2025. The contract is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the VA Strategic...
This is a firm fixed price definitive contract awarded by the Veterans Integrated Service Network 17 of the Department of Veterans Affairs to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for $1,010,000.00 and has a period of performance through September 30, 2028. The contract is for genetics testing services, including clinical genetic testing, germline genetic testing utilizing whole genome sequencing, custom gene...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for germline genetic testing services. The contract has a ceiling value of $95,817.89 and a period of performance through September 30, 2018. It was awarded as a total small business set-aside. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits and services to various federal agencies, including the VA,...
The Department of Veterans Affairs Veterans Health Administration awarded Fulgent Therapeutics LLC a $3.2 million firm fixed price delivery order against its Medical Laboratory Testing and Analysis Services GSA Schedule contract. Fulgent Therapeutics, doing business as Fulgent Diagnostics and a division of Fulgent Genetics, will provide COVID-19 cost per test services to VHA's Veterans Integrated Service Network 21 through December 2020. The contract supports VHA's coronavirus disease testing...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for the delivery of laboratory testing kits, with a ceiling value of $889,097.43 and a period of performance through December 30, 2024. There was no set-aside designation used for this award. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for SARS-COV-2 genomic sequencing services. The firm fixed price contract has a potential value of $40,517,395.00 and a completion date of March 10, 2022. Fulgent Diagnostics is a division of Fulgent Genetics, Inc. and has provided genetic and genomic testing services to various federal agencies,...
This federal contract award was issued by the Veterans Integrated Service Network 6 (VISN 6), a division of the U.S. Department of Veterans Affairs (VA), to Prevention Genetics LLC, a for-profit limited liability company that provides genetic testing services. The $55,800 firm-fixed-price purchase order is for the provision of genetic testing panels, excluding exome testing, with a period of performance through March 21, 2024. The original solicitation was issued by the Richmond VA Medical...
This federal contract award is for germline genetic testing services provided by Preventiongenetics LLC (dba Prevention Genetics), a for-profit limited liability company, to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 19. The contract, valued at $2,051,180.00, is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. The contract was awarded on September 28, 2023, with an ultimate completion date of September 27, 2024. The...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $104,500 firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for the procurement of next generation DNA sequencing services. Fulgent Therapeutics is a subsidiary of Fulgent Genetics, Inc. and has previously provided genetic and genomic testing services to various federal agencies, including the...